Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
6.02
+0.14 (2.38%)
Apr 29, 2026, 3:04 PM CST
Market Cap4.51B +26.4%
Revenue (ttm)2.88B +21.4%
Net Income27.56M -72.5%
EPS0.04 -72.7%
Shares Out749.98M
PE Ratio170.54
Forward PE20.07
Dividend0.10 (1.70%)
Ex-Dividend DateJun 6, 2025
Volume17,185,437
Average Volume16,078,802
Open5.71
Previous Close5.88
Day's Range5.71 - 6.05
52-Week Range5.56 - 8.06
Beta0.50
RSI54.23
Earnings DateApr 29, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Financial Statements